Search

everythinglearnresearchcommunity

for

Search:↓

Alzheimer's patients have higher levels of certain chemicals in their hair.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

DFMO may help control hair growth and treat cancer.

Hair analysis for drugs in psychosis patients is unreliable due to varying hair growth rates.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Finasteride and dutasteride may increase the risk of depression and suicidality, so patients should be monitored closely.

FDA-approved medications are important for treating high blood pressure in children, but non-approved ones can be used if needed.

Divalproex sodium can unexpectedly cause agitation and hyperactivity in some patients.

Chitosan-coated dutasteride nanocapsules improve hair treatment, and physical stimulation boosts effectiveness.

Finasteride may help reduce opioid use.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Blocking certain brain processes reduces mating behavior in female rats.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

The article concludes that the wool follicle is a valuable model for studying tissue interactions and has potential for genetic improvements in wool production.

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Finasteride improves hair loss in women with hyperandrogenism.

The circadian clock is crucial for tissue renewal and regeneration, affecting stem cell functions and having implications for health and disease.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Fibroblasts can be turned into melanocytes for potential skin treatments.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.